Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders | Journal of Neuroinflammation | Full Text
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies
Figure Model contrasting the potential role of antibodies to myelin oligodendrocyte glycoprotein (MOG) or aquaporin-4 (AQP4) in opticospinal inflammationMOG-specific. - ppt download
IJMS | Free Full-Text | Cells to the Rescue: Emerging Cell-Based Treatment Approaches for NMOSD and MOGAD
Diagnostic implications of MOG/AQP4 antibodies in recurrent optic neuritis
Clinicoradiological comparative study of Aquaporin-4-IgG seropositive neuromyelitis optica spectrum disorder (NMOSD) and MOG antibody associated disease (MOGAD): A prospective observational study and review of literature - ScienceDirect
Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? | Neurology Neuroimmunology & Neuroinflammation
Frontiers | Serum and Cerebrospinal Fluid Biomarkers in Neuromyelitis Optica Spectrum Disorder and Myelin Oligodendrocyte Glycoprotein Associated Disease
Brain lesions caused by MOG-IgG and AQP4-IgG. Mice received... | Download Scientific Diagram
Does MOG Ig-positive AQP4-seronegative opticospinal inflammatory disease justify a diagnosis of NMO spectrum disorder? | Neurology Neuroimmunology & Neuroinflammation
Vicente Martín on Twitter: "MOG in NMOSD Patients They have a different immunopathogenic mechanism in MOG-IgG–positive Neuromyelitis Optica Spectrum Disorders patients With some clinical, epidemiologic, and radiologic features distinct from those in
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD - ScienceDirect
A Longitudinal Comparison of the Recovery Patterns of Optic Neuritis with MOG Antibody-Seropositive and AQP4 Antibody-Seropositive or -Seronegative for Both Antibodies